Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors

doi:10.1084/jem.175.2.323

This Article

	Full Text (PDF)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Aderka, D.
	Articles by Wallach, D.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Aderka, D.
	Articles by Wallach, D.


Social Bookmarking

	What's this?

ARTICLES

Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors

D Aderka, H Engelmann, Y Maor, C Brakebusch and D Wallach
Department of Medicine T, Tel-Aviv Medical Center, Sackler Faculty of Medicine, Tel-Aviv University, Israel.

The receptors for tumor necrosis factor (TNF) exist in cell-associated as well as soluble forms, both binding specifically to TNF. Since the soluble forms of TNF receptors (sTNF-Rs) can compete with the cell- associated TNF receptors for TNF, it was suggested that they function as inhibitors of TNF activity; at high concentrations, the sTNF-Rs indeed inhibit TNF effects. However, we report here that in the presence of low concentrations of the sTNF-Rs, effects of TNF whose induction depend on prolonged treatment with this cytokine are augmented, reflecting an attenuation by the sTNF-Rs of spontaneous TNF activity decay. Evidence that this stabilization of TNF activity by the sTNF-Rs follows from stabilization of TNF structure within the complexes that TNF forms with the sTNF-Rs is presented here, suggesting that the sTNF-Rs can affect TNF activity not only by interfering with its binding to cells but also by stabilizing its structure and preserving its activity, thus augmenting some of its effects.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Nicol, M. Q., Mathys, J.-M., Pereira, A., Ollington, K., Ieong, M. H., Skolnik, P. R. (2008). Human Immunodeficiency Virus Infection Alters Tumor Necrosis Factor Alpha Production via Toll-Like Receptor-Dependent Pathways in Alveolar Macrophages and U1 Cells. J. Virol. 82: 7790-7798 [Abstract] [Full Text]
Hise, M., Compher, C., Brown, J. (2008). Inflammatory Mediators and Home Parenteral Nutrition. Nutr Clin Pract 23: 42-48 [Abstract] [Full Text]
Shibata, H., Yoshioka, Y., Ohkawa, A., Minowa, K., Mukai, Y., Abe, Y., Taniai, M., Nomura, T., Kayamuro, H., Nabeshi, H., Sugita, T., Imai, S., Nagano, K., Yoshikawa, T., Fujita, T., Nakagawa, S., Yamamoto, A., Ohta, T., Hayakawa, T., Mayumi, T., Vandenabeele, P., Aggarwal, B. B., Nakamura, T., Yamagata, Y., Tsunoda, S.-i., Kamada, H., Tsutsumi, Y. (2008). Creation and X-ray Structure Analysis of the Tumor Necrosis Factor Receptor-1-selective Mutant of a Tumor Necrosis Factor-{alpha} Antagonist. J. Biol. Chem. 283: 998-1007 [Abstract] [Full Text]
Wati, S., Li, P., Burrell, C. J., Carr, J. M. (2007). Dengue Virus (DV) Replication in Monocyte-Derived Macrophages Is Not Affected by Tumor Necrosis Factor Alpha (TNF-{alpha}), and DV Infection Induces Altered Responsiveness to TNF-{alpha} Stimulation. J. Virol. 81: 10161-10171 [Abstract] [Full Text]
Brackett, N. L., Cohen, D. R., Ibrahim, E., Aballa, T. C., Lynne, C. M. (2007). Neutralization of Cytokine Activity at the Receptor Level Improves Sperm Motility in Men With Spinal Cord Injuries. J Androl 28: 717-721 [Abstract] [Full Text]
McKenna, S. D., Feger, G., Kelton, C., Yang, M., Ardissone, V., Cirillo, R., Vitte, P.-A., Jiang, X., Campbell, R. K. (2007). Tumor Necrosis Factor (TNF)-Soluble High-Affinity Receptor Complex as a TNF Antagonist. J. Pharmacol. Exp. Ther. 322: 822-828 [Abstract] [Full Text]
Sugita, S., Takase, H., Taguchi, C., Mochizuki, M. (2007). The Role of Soluble TNF Receptors for TNF-{alpha} in Uveitis. IOVS 48: 3246-3252 [Abstract] [Full Text]
Esposito, E., Mazzon, E., Muia, C., Meli, R., Sessa, E., Cuzzocrea, S. (2007). Splanchnic ischemia and reperfusion injury is reduced by genetic or pharmacological inhibition of TNF-{alpha}. J. Leukoc. Biol. 81: 1032-1043 [Abstract] [Full Text]
Shing, C. M., Peake, J., Suzuki, K., Okutsu, M., Pereira, R., Stevenson, L., Jenkins, D. G., Coombes, J. S. (2007). Effects of bovine colostrum supplementation on immune variables in highly trained cyclists. J. Appl. Physiol. 102: 1113-1122 [Abstract] [Full Text]
Sather, S., Kenyon, K. D., Lefkowitz, J. B., Liang, X., Varnum, B. C., Henson, P. M., Graham, D. K. (2007). A soluble form of the Mer receptor tyrosine kinase inhibits macrophage clearance of apoptotic cells and platelet aggregation. Blood 109: 1026-1033 [Abstract] [Full Text]
Gosman, G. G., Katcher, H. I., Legro, R. S. (2006). Obesity and the role of gut and adipose hormones in female reproduction. Hum Reprod Update 12: 585-601 [Abstract] [Full Text]
Esteve, E., Castro, A., Lopez-Bermejo, A., Vendrell, J., Ricart, W., Fernandez-Real, J.-M. (2006). Divergent Relationships Among Soluble Tumor Necrosis Factor-{alpha} Receptors 1 and 2, Insulin Resistance, and Endothelial Function.. Diabetes Care 29: 1460-1461 [Full Text]
Fernandez-Real, J. M., Straczkowski, M., Lainez, B., Chacon, M. R, Kowalska, I., Lopez-Bermejo, A., Garcia-Espana, A., Nikolajuk, A., Kinalska, I., Ricart, W. (2006). An alternative spliced variant of circulating soluble tumor necrosis factor-{alpha} receptor-2 is paradoxically associated with insulin action.. Eur J Endocrinol 154: 723-730 [Abstract] [Full Text]
Lecube, A., Hernandez, C., Genesca, J., Simo, R. (2006). Glucose Abnormalities in Patients with Hepatitis C Virus Infection: Epidemiology and pathogenesis. Diabetes Care 29: 1140-1149 [Full Text]
Sandberg, W. J., Yndestad, A., Oie, E., Smith, C., Ueland, T., Ovchinnikova, O., Robertson, A.-K. L., Muller, F., Semb, A. G., Scholz, H., Andreassen, A. K., Gullestad, L., Damas, J. K., Froland, S. S., Hansson, G. K., Halvorsen, B., Aukrust, P. (2006). Enhanced T-Cell Expression of RANK Ligand in Acute Coronary Syndrome: Possible Role in Plaque Destabilization. Arterioscler. Thromb. Vasc. Bio. 26: 857-863 [Abstract] [Full Text]
Kowalska, I., Straczkowski, M., Nikolajuk, A., Krukowska, A., Kinalska, I., Gorska, M. (2006). Plasma adiponectin concentration and tumor necrosis factor-{alpha} system activity in lean non-diabetic offspring of type 2 diabetic subjects. Eur J Endocrinol 154: 319-324 [Abstract] [Full Text]
Nowlan, M. L., Drewe, E., Bulsara, H., Esposito, N., Robins, R. A., Tighe, P. J., Powell, R. J., Todd, I. (2006). Systemic cytokine levels and the effects of etanercept in TNF receptor-associated periodic syndrome (TRAPS) involving a C33Y mutation in TNFRSF1A. Rheumatology (Oxford) 45: 31-37 [Abstract] [Full Text]
Rojas-Cartagena, C., Appleyard, C. B., Santiago, O. I., Flores, I. (2005). Experimental Intestinal Endometriosis Is Characterized by Increased Levels of Soluble TNFRSF1B and Downregulation of Tnfrsf1a and Tnfrsf1b Gene Expression. Biol. Reprod. 73: 1211-1218 [Abstract] [Full Text]
Braun, C., Hamacher, J., Morel, D. R., Wendel, A., Lucas, R. (2005). Dichotomal Role of TNF in Experimental Pulmonary Edema Reabsorption. J. Immunol. 175: 3402-3408 [Abstract] [Full Text]
Jit, M., Henderson, B., Stevens, M., Seymour, R. M. (2005). TNF-{alpha} neutralization in cytokine-driven diseases: a mathematical model to account for therapeutic success in rheumatoid arthritis but therapeutic failure in systemic inflammatory response syndrome. Rheumatology (Oxford) 44: 323-331 [Abstract] [Full Text]
Dai, H., Guzman, J., Chen, B., Costabel, U. (2005). Production of Soluble Tumor Necrosis Factor Receptors and Tumor Necrosis Factor-{alpha} by Alveolar Macrophages in Sarcoidosis and Extrinsic Allergic Alveolitis. Chest 127: 251-256 [Abstract] [Full Text]
Bachetti, T., Comini, L., Pasini, E., Ferrari, R. (2004). Anti-cytokine therapy in chronic heart failure: new approaches and unmet promises. Eur Heart J Suppl 6: F16-F21 [Abstract] [Full Text]
Gonzalez-Calvin, J. L., Gallego-Rojo, F., Fernandez-Perez, R., Casado-Caballero, F., Ruiz-Escolano, E., Olivares, E. G. (2004). Osteoporosis, Mineral Metabolism, and Serum Soluble Tumor Necrosis Factor Receptor p55 in Viral Cirrhosis. J. Clin. Endocrinol. Metab. 89: 4325-4330 [Abstract] [Full Text]
Coers, J., Ranft, C., Skoda, R. C. (2004). A Truncated Isoform of c-Mpl with an Essential C-terminal Peptide Targets the Full-length Receptor for Degradation. J. Biol. Chem. 279: 36397-36404 [Abstract] [Full Text]
van Dielen, F. M. H., Buurman, W. A., Hadfoune, M., Nijhuis, J., Greve, J. W. (2004). Macrophage Inhibitory Factor, Plasminogen Activator Inhibitor-1, Other Acute Phase Proteins, and Inflammatory Mediators Normalize as a Result of Weight Loss in Morbidly Obese Subjects Treated with Gastric Restrictive Surgery. J. Clin. Endocrinol. Metab. 89: 4062-4068 [Abstract] [Full Text]
Mozaffarian, D., Pischon, T., Hankinson, S. E, Rifai, N., Joshipura, K., Willett, W. C, Rimm, E. B (2004). Dietary intake of trans fatty acids and systemic inflammation in women. Am. J. Clin. Nutr. 79: 606-612 [Abstract] [Full Text]
Hawari, F. I., Rouhani, F. N., Cui, X., Yu, Z.-X., Buckley, C., Kaler, M., Levine, S. J. (2004). Release of full-length 55-kDa TNF receptor 1 in exosome-like vesicles: A mechanism for generation of soluble cytokine receptors. Proc. Natl. Acad. Sci. USA 101: 1297-1302 [Abstract] [Full Text]
Lainez, B., Fernandez-Real, J. M., Romero, X., Esplugues, E., Canete, J. D., Ricart, W., Engel, P. (2004). Identification and characterization of a novel spliced variant that encodes human soluble tumor necrosis factor receptor 2. Int Immunol 16: 169-177 [Abstract] [Full Text]
Mohammed, F F, Smookler, D S, Khokha, R (2003). Metalloproteinases, inflammation, and rheumatoid arthritis. Ann Rheum Dis 62: ii43-47 [Abstract] [Full Text]
Chung, E. S., Packer, M., Lo, K. H., Fasanmade, A. A., Willerson, J. T. (2003). Randomized, Double-Blind, Placebo-Controlled, Pilot Trial of Infliximab, a Chimeric Monoclonal Antibody to Tumor Necrosis Factor-{alpha}, in Patients With Moderate-to-Severe Heart Failure: Results of the Anti-TNF Therapy Against Congestive Heart failure (ATTACH) Trial. Circulation 107: 3133-3140 [Abstract] [Full Text]
Fernandez-Real, J. M., Ricart, W. (2003). Insulin Resistance and Chronic Cardiovascular Inflammatory Syndrome. Endocr. Rev. 24: 278-301 [Abstract] [Full Text]
Pandey, M., Tuncman, G., Hotamisligil, G. S., Samad, F. (2003). Divergent Roles for p55 and p75 TNF-{alpha} Receptors in the Induction of Plasminogen Activator Inhibitor-1. Am. J. Pathol. 162: 933-941 [Abstract] [Full Text]
Schumann, J., Muhlen, K., Kiemer, A. K., Vollmar, A. M., Tiegs, G. (2003). Parenchymal, But Not Leukocyte, TNF Receptor 2 Mediates T Cell-Dependent Hepatitis in Mice. J. Immunol. 170: 2129-2137 [Abstract] [Full Text]
Fernandez-Real, J.-M., Pugeat, M., Grasa, M., Broch, M., Vendrell, J., Brun, J., Ricart, W. (2002). Serum Corticosteroid-Binding Globulin Concentration and Insulin Resistance Syndrome: A Population Study. J. Clin. Endocrinol. Metab. 87: 4686-4690 [Abstract] [Full Text]
Straczkowski, M., Kowalska, I., Stepien, A., Dzienis-Straczkowska, S., Szelachowska, M., Kinalska, I. (2002). Increased Plasma-Soluble Tumor Necrosis Factor-{alpha} Receptor 2 Level in Lean Nondiabetic Offspring of Type 2 Diabetic Subjects. Diabetes Care 25: 1824-1828 [Abstract] [Full Text]
Peral, B., San Millan, J. L., Castello, R., Moghetti, P., Escobar-Morreale, H. F. (2002). The Methionine 196 Arginine Polymorphism in Exon 6 of the TNF Receptor 2 Gene (TNFRSF1B) Is Associated with the Polycystic Ovary Syndrome and Hyperandrogenism. J. Clin. Endocrinol. Metab. 87: 3977-3983 [Abstract] [Full Text]
Burzyn, D., Jancic, C. C., Zittermann, S., Keller Sarmiento, M. I., Fainboim, L., Rosenstein, R. E., Chuluyan, H. E. (2002). Decrease in cAMP levels modulates adhesion to fibronectin and immunostimulatory ability of human dendritic cells. J. Leukoc. Biol. 72: 93-100 [Abstract] [Full Text]
IONESCU, A. A., NIXON, L. S., LUZIO, S., LEWIS-JENKINS, V., EVANS, W. D., STONE, M. D., OWENS, D. R., ROUTLEDGE, P. A., SHALE, D. J. (2002). Pulmonary Function, Body Composition, and Protein Catabolism in Adults with Cystic Fibrosis. Am. J. Respir. Crit. Care Med. 165: 495-500 [Abstract] [Full Text]
Verleden, G.M., du Bois, R.M., Bouros, D., Drent, M., Millar, A., Muller-Quernheim, J., Semenzato, G., Johnson, S., Sourvinos, G., Olivieri, D., Pietinalho, A., Xaubet, A. (2001). Genetic predisposition and pathogenetic mechanisms of interstitial lung diseases of unknown origin. Eur Respir J 18: 17S-29s [Abstract] [Full Text]
Limb, G. A., Hollifield, R. D., Webster, L., Charteris, D. G., Chignell, A. H. (2001). Soluble TNF Receptors in Vitreoretinal Proliferative Disease. IOVS 42: 1586-1591 [Abstract] [Full Text]
O'GRADY, N. P., PREAS, H. L. II, PUGIN, J., FIUZA, C., TROPEA, M., REDA, D., BANKS, S. M., SUFFREDINI, A. F. (2001). Local Inflammatory Responses following Bronchial Endotoxin Instillation in Humans. Am. J. Respir. Crit. Care Med. 163: 1591-1598 [Abstract] [Full Text]
Benjafield, A. V., Glenn, C. L., Wang, X. L., Colagiuri, S., Morris, B. J. (2001). TNFRSF1B in Genetic Predisposition to Clinical Neuropathy and Effect on HDL Cholesterol and Glycosylated Hemoglobin in Type 2 Diabetes. Diabetes Care 24: 753-757 [Abstract] [Full Text]
Cannon, J. G. (2000). Inflammatory Cytokines in Nonpathological States. Physiology 15: 298-303 [Abstract] [Full Text]
Jin, L., Raymond, D. P., Crabtree, T. D., Pelletier, S. J., Houlgrave, C. W., Pruett, T. L., Sawyer, R. G. (2000). Enhanced Murine Macrophage TNF Receptor Shedding by Cytosine-Guanine Sequences in Oligodeoxynucleotides. J. Immunol. 165: 5153-5160 [Abstract] [Full Text]
Dinarello, C. A (2000). Targeting interleukin 18 with interleukin 18 binding protein. Ann Rheum Dis 59: i17-20 [Abstract] [Full Text]
Selmaj, K. W (2000). Tumour necrosis factor and anti-tumour necrosis factor approach to inflammatory demyelinating diseases of the central nervous system. Ann Rheum Dis 59: i94-102 [Full Text]
Marano, C. W., Garulacan, L. A., Laughlin, K. V., Igidbashian, L., Trace, C., Goldman, S. M., Sutter, F. P., Reichard, G. A. Jr, Mullin, J. M. (2000). Plasma concentrations of soluble tumor necrosis factor receptor I and tumor necrosis factor during cardiopulmonary bypass. Ann. Thorac. Surg. 70: 1313-1318 [Abstract] [Full Text]
Probert, L., Eugster, H.-P., Akassoglou, K., Bauer, J., Frei, K., Lassmann, H., Fontana, A. (2000). TNFR1 signalling is critical for the development of demyelination and the limitation of T-cell responses during immune-mediated CNS disease. Brain 123: 2005-2019 [Abstract] [Full Text]
Geurts, J. M.W., Janssen, R. G.J.H., van Greevenbroek, M. M.J., van der Kallen, C. J.H., Cantor, R. M., Bu, X.-d., Aouizerat, B. E., Allayee, H., Rotter, J. I., de Bruin, T. W.A. (2000). Identification of TNFRSF1B as a novel modifier gene in familial combined hyperlipidemia. Hum Mol Genet 9: 2067-2074 [Abstract] [Full Text]
IONESCU, A. A., NIXON, L. S., EVANS, W. D., STONE, M. D., LEWIS-JENKINS, V., CHATHAM, K., SHALE, D. J. (2000). Bone Density, Body Composition, and Inflammatory Status in Cystic Fibrosis. Am. J. Respir. Crit. Care Med. 162: 789-794 [Abstract] [Full Text]
Dri, P., Gasparini, C., Menegazzi, R., Cramer, R., Alberi, L., Presani, G., Garbisa, S., Patriarca, P. (2000). TNF-Induced Shedding of TNF Receptors in Human Polymorphonuclear Leukocytes: Role of the 55-kDa TNF Receptor and Involvement of a Membrane-Bound and Non-Matrix Metalloproteinase. J. Immunol. 165: 2165-2172 [Abstract] [Full Text]
Glenn, C. L., Wang, W. Y.S., Benjafield, A. V., Morris, B. J. (2000). Linkage and association of tumor necrosis factor receptor 2 locus with hypertension, hypercholesterolemia and plasma shed receptor. Hum Mol Genet 9: 1943-1949 [Abstract] [Full Text]
Berry, C, Clark, A.L (2000). Catabolism in chronic heart failure. Eur Heart J 21: 521-532
Herbein, G., O'brien, W. A. (2000). Tumor Necrosis Factor (TNF)-{alpha} and TNF Receptors in Viral Pathogenesis. Exp. Biol. Med. 223: 241-257 [Abstract] [Full Text]
Kim, S.-H., Eisenstein, M., Reznikov, L., Fantuzzi, G., Novick, D., Rubinstein, M., Dinarello, C. A. (2000). Structural requirements of six naturally occurring isoforms of the IL-18 binding protein to inhibit IL-18. Proc. Natl. Acad. Sci. USA 97: 1190-1195 [Abstract] [Full Text]
Grunewald, R. W., Fiedler, G. M., Stock, B., Grunewald, J. M., Muller, G. A. (2000). Soluble CD-4 and CD-8 as markers of immunological activation in renal transplant recipients. Nephrol Dial Transplant 15: 71-77 [Abstract] [Full Text]
Tsao, T. C. Y., Hong, J.-h., Li, L.-F., Hsieh, M.-J., Liao, S.-K., Chang, K. S. S. (2000). Imbalances Between Tumor Necrosis Factor-{alpha} and Its Soluble Receptor Forms, and Interleukin-1{beta} and Interleukin-1 Receptor Antagonist in BAL Fluid of Cavitary Pulmonary Tuberculosis*. Chest 117: 103-109 [Abstract] [Full Text]
Corti, A., Fattorini, L., Thoresen, O. F., Ricci, M. L., Gallizia, A., Pelagi, M., Li, Y., Orefici, G. (1999). Upregulation of p75 Tumor Necrosis Factor Alpha Receptor in Mycobacterium avium-Infected Mice: Evidence for a Functional Role. Infect. Immun. 67: 5762-5767 [Abstract] [Full Text]
Jurewicz, A. M., Walczak, A. K., Selmaj, K. W. (1999). Shedding of TNF receptors in multiple sclerosis patients. Neurology 53: 1409-1409 [Abstract] [Full Text]
Raina, N., Lamarre, J., Liew, C.-C., Lofti, A. H., Jeejeebhoy, K. N. (1999). Effect of nutrition on tumor necrosis factor receptors in weight-gaining and -losing rats. Am. J. Physiol. Endocrinol. Metab. 277: E464-E473 [Abstract] [Full Text]
Khoury, S. J., Orav, E. J., Guttmann, C. R. G., Kikinis, R., Jolesz, F. A., Weiner, H. L. (1999). Changes in serum levels of ICAM and TNF-R correlate with disease activity in multiple sclerosis. Neurology 53: 758-758 [Abstract] [Full Text]
Quattrocchi, E., Walmsley, M., Browne, K., Williams, R. O., Marinova-Mutafchieva, L., Buurman, W., Butler, D. M., Feldmann, M. (1999). Paradoxical Effects of Adenovirus-Mediated Blockade of TNF Activity in Murine Collagen-Induced Arthritis. J. Immunol. 163: 1000-1009 [Abstract] [Full Text]
SHIRIN, H, MOSS, S F (1999). A key cytokine unlocks the door. Gut 45: 5-6 [Full Text]
Dibbs, Z., Thornby, J., White, B. G., Mann, D. L. (1999). Natural variability of circulating levels of cytokines and cytokine receptors in patients with heart failure: implications for clinical trials. J Am Coll Cardiol 33: 1935-1942 [Abstract] [Full Text]
Armstrong, L., Foley, N. M, Millar, A. B (1999). Inter-relationship between tumour necrosis factor-alpha (TNF-alpha ) and TNF soluble receptors in pulmonary sarcoidosis. Thorax 54: 524-530 [Abstract] [Full Text]
Madge, L. A., Sierra-Honigmann, M. R., Pober, J. S. (1999). Apoptosis-inducing Agents Cause Rapid Shedding of Tumor Necrosis Factor Receptor 1�(TNFR1). A NONPHARMACOLOGICAL EXPLANATION FOR INHIBITION OF TNF-MEDIATED ACTIVATION. J. Biol. Chem. 274: 13643-13649 [Abstract] [Full Text]
Aziz, N., Nishanian, P., Mitsuyasu, R., Detels, R., Fahey, J. L. (1999). Variables That Affect Assays for Plasma Cytokines and Soluble Activation Markers. CVI 6: 89-95 [Abstract] [Full Text]
Munk, M. E., Anding, P., SchettinI, A. P.�M., Cunha, M. d. G. S., Kaufmann, S. H.�E. (1999). Soluble Tumor Necrosis Factor Alpha Receptors in Sera from Leprosy Patients. Infect. Immun. 67: 423-425 [Abstract] [Full Text]
Smith, S., Skerrett, S. J., Chi, E. Y., Jonas, M., Mohler, K., Wilson, C. B. (1998). The locus of tumor necrosis factor-alpha action in lung inflammation.. Am. J. Respir. Cell Mol. Bio. 19: 881-891 [Abstract] [Full Text]
Olszyna, D. P., Prins, J. M., Buis, B., van Deventer, S. J.�H., Speelman, P., van der Poll, T. (1998). Levels of Inhibitors of Tumor Necrosis Factor Alpha and Interleukin 1beta in Urine and Sera of Patients with Urosepsis. Infect. Immun. 66: 3527-3534 [Abstract] [Full Text]
Ksontini, R., MacKay, S. L. D., Moldawer, L. L. (1998). Revisiting the Role of Tumor Necrosis Factor {alpha} and the Response to Surgical Injury and Inflammation. Arch Surg 133: 558-567 [Abstract] [Full Text]
Ballinger, A B, Woolley, J A, Ahmed, M, Mulcahy, H, Alstead, E M, Landon, J, Clark, M L, Farthing, M J G (1998). Persistent systemic inflammatory response after stent insertion in patients with malignant bile duct obstruction. Gut 42: 555-559 [Abstract] [Full Text]
Le, Q., Daniel, R., Chung, S.-W., Kang, A. D., Eisenstein, T. K., Sultzer, B. M., Simpkins, H., Wong, P. M. C. (1998). Involvement of C-Abl Tyrosine Kinase in Lipopolysaccharide- Induced Macrophage Activation. J. Immunol. 160: 3330-3336 [Abstract] [Full Text]
Herman, C., Chernajovsky, Y. (1998). Mutation of Proline 211 Reduces Shedding of the Human p75 TNF Receptor. J. Immunol. 160: 2478-2487 [Abstract] [Full Text]
Ferrari, R. (1998). Tumor necrosis factor in CHF: a double facet cytokine. Cardiovasc Res 37: 554-559 [Full Text]
Mwatha, J. K., Kimani, G., Kamau, T., Mbugua, G. G., Ouma, J. H., Mumo, J., Fulford, A. J. C., Jones, F. M., Butterworth, A. E., Roberts, M. B., Dunne, D. W. (1998). High Levels of TNF, Soluble TNF Receptors, Soluble ICAM-1, and IFN-{gamma}, but Low Levels of IL-5, Are Associated with Hepatosplenic Disease in Human Schistosomiasis Mansoni. J. Immunol. 160: 1992-1999 [Abstract] [Full Text]
Peschon, J. J., Torrance, D. S., Stocking, K. L., Glaccum, M. B., Otten, C., Willis, C. R., Charrier, K., Morrissey, P. J., Ware, C. B., Mohler, K. M. (1998). TNF Receptor-Deficient Mice Reveal Divergent Roles for p55 and p75 in Several Models of Inflammation. J. Immunol. 160: 943-952 [Abstract] [Full Text]
Tinkle, S., Newman, L. (1997). Beryllium-stimulated release of tumor necrosis factor-alpha, interleukin-6, and their soluble receptors in chronic beryllium disease. Am. J. Respir. Crit. Care Med. 156: 1884-1891 [Abstract] [Full Text]
Dickensheets, H. L., Freeman, S. L., Smith Jr, M. F., Donnelly, R. P. (1997). Interleukin-10 Upregulates Tumor Necrosis Factor Receptor Type-II (p75) Gene Expression in Endotoxin-Stimulated Human Monocytes. Blood 90: 4162-4171 [Abstract] [Full Text]
VISCARDI, R.�M., HASDAY, J.�D., GUMPPER, K.�F., TACIAK, V., CAMPBELL, A.�B., PALMER, T.�W. (1997). Cromolyn Sodium Prophylaxis Inhibits Pulmonary Proinflammatory Cytokines in Infants at High Risk for Bronchopulmonary Dysplasia. Am. J. Respir. Crit. Care Med. 156: 1523-1529 [Abstract] [Full Text]
Mantzoros, C. S., Moschos, S., Avramopoulos, I., Kaklamani, V., Liolios, A., Doulgerakis, D. E., Griveas, I., Katsilambros, N., Flier, J. S. (1997). Leptin Concentrations in Relation to Body Mass Index and the Tumor Necrosis Factor-{alpha} System in Humans. J. Clin. Endocrinol. Metab. 82: 3408-3413 [Abstract] [Full Text]
Hestdal, K., Aukrust, P., Muller, F., Lien, E., Bjerkeli, V., Espevik, T., Froland, S. S. (1997). Dysregulation of Membrane-Bound Tumor Necrosis Factor-alpha and Tumor Necrosis Factor Receptors on Mononuclear Cells in Human Immunodeficiency Virus Type 1�Infection: Low Percentage of p75-Tumor Necrosis Factor Receptor Positive Cells in Patients With Advanced Disease and High Viral Load. Blood 90: 2670-2679 [Abstract] [Full Text]
Medvedev, A. E., Espevik, T., Ranges, G., Sundan, A. (1996). Distinct Roles of the Two Tumor Necrosis Factor (TNF) Receptors in Modulating TNF and Lymphotoxin alpha Effects. J. Biol. Chem. 271: 9778-9784 [Abstract] [Full Text]
Packer, M. (1995). Is Tumor Necrosis Factor an Important Neurohormonal Mechanism in Chronic Heart Failure?. Circulation 92: 1379-1382 [Full Text]
Ferrari, R., Bachetti, T., Confortini, R., Opasich, C., Febo, O., Corti, A., Cassani, G., Visioli, O. (1995). Tumor Necrosis Factor Soluble Receptors in Patients With Various Degrees of Congestive Heart Failure. Circulation 92: 1479-1486 [Abstract] [Full Text]
Tan, J. C., Braun, S., Rong, H., DiGiacomo, R., Dolphin, E., Baldwin, S., Narula, S. K., Zavodny, P. J., Chou, C.-C. (1995). Characterization of Recombinant Extracellular Domain of Human Interleukin-10 Receptor. J. Biol. Chem. 270: 12906-12911 [Abstract] [Full Text]
Otto, F., Seiz, A., Galanos, C., Mertelsmann, R., Engelhardt, R. (1995). Soluble tumor necrosis factor receptors are released independent of TNF in endotoxemia. Innate Immunity 2: 85-89 [Abstract]
Ameloot, P., Fiers, W., De Bleser, P., Ware, C. F., Vandenabeele, P., Brouckaert, P. (2001). Identification of Tumor Necrosis Factor (TNF) Amino Acids Crucial for Binding to the Murine p75 TNF Receptor and Construction of Receptor-selective Mutants. J. Biol. Chem. 276: 37426-37430 [Abstract] [Full Text]
Ameloot, P., Declercq, W., Fiers, W., Vandenabeele, P., Brouckaert, P. (2001). Heterotrimers Formed by Tumor Necrosis Factors of Different Species or Muteins. J. Biol. Chem. 276: 27098-27103 [Abstract] [Full Text]
Fernandez-Real, J.-M., Lainez, B., Vendrell, J., Rigla, M., Castro, A., Penarroja, G., Broch, M., Perez, A., Richart, C., Engel, P., Ricart, W. (2002). Shedding of TNF-alpha receptors, blood pressure, and insulin sensitivity in type 2 diabetes mellitus. Am. J. Physiol. Endocrinol. Metab. 282: E952-E959 [Abstract] [Full Text]